Paper8448115
Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding.
Satyanarayana S and 2 others. Biochemistry, 1993. Cited by 558 papers, by iCite.
Cite this record
ConductScience Library. Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. Papers, record 8448115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8448115
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA | Major topic |
| Intercalating Agents | Major topic |
| Organometallic Compounds | Major topic |
| Phenanthrolines | Major topic |
| Ruthenium | Major topic |
| Binding Sites | |
| Circular Dichroism | |
| Ferricyanides | |
| Isomerism | |
| Kinetics | |
| Nucleic Acid Denaturation | |
| Spectrometry, Fluorescence | |
| Spectrophotometry | |
| Structure-Activity Relationship | |
| Viscosity |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA35635 | NCI NIH HHS | United States | R01CA035635 | PubMed and NIH |
Source NIH RePORTER
Cited by94
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 558 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39992325 | Effect of 6,6-Substitution on 2,2'-Bipyridine and Probing Biomolecular Interaction Through Experimental and Computational Studies Towards Anticancer Potency. | J Fluoresc | 2025 | https://conductscience.org/library/papers/39992325 | PubMed |
| 39811293 | Towards targeted cancer therapy: Synthesis, characterization, and biological activity of a new Cu(II)-ibuprofen-2,2'-dipyridylamine metal complex. | Heliyon | 2025 | https://conductscience.org/library/papers/39811293 | PubMed |
| 39031237 | An In-Silico Drug Designing Approach Attempted on a Newly Synthesized Co(II) Complex along with its Other Biological Activities: A Combined Investigation of both Experimental and Theoretical Aspects. | J Fluoresc | 2025 | https://conductscience.org/library/papers/39031237 | PubMed |
| 38613713 | Synthesis and Characterization of Zn(II) Complex of 4-chloro-2-(((2-phenoxyphenyl)imino)methyl)phenol and its Biological Efficacies: DNA Interaction, ADMET, DFT and Molecular Docking Study. | J Fluoresc | 2025 | https://conductscience.org/library/papers/38613713 | PubMed |
| 38602589 | Application of Novel Ruthenium (II) Polypyridyl Complexes as Robust DNA Probes, Optical Material and Antimicrobials-An Experimental and DFT Approach. | J Fluoresc | 2025 | https://conductscience.org/library/papers/38602589 | PubMed |
| 38393498 | Synthesis of Novel [{(2-Amino-5-Nitro-N-[(E)-Thiophen-2-yl-Methylidene]Aniline-κ3N1:N4:S)(Sulphato-κ2O1:O3)}Zinc(II)] Complex with Physico-Chemical and Biological Perspective Exploration: A Combined Experimental and Computational Studies. | J Fluoresc | 2025 | https://conductscience.org/library/papers/38393498 | PubMed |
| 37867880 | Synthesis, structural characterization, antioxidant, cytotoxic activities and docking studies of schiff base Cu(II) complexes. | Heliyon | 2023 | https://conductscience.org/library/papers/37867880 | PubMed |
| 37705997 | Deciphering the binding mechanism of an anti-cancer phytochemical plumbagin with calf thymus DNA using biophysical and in silico techniques. | Front Chem | 2023 | https://conductscience.org/library/papers/37705997 | PubMed |
| 37477757 | Interactions of arene ruthenium(II) complexes [η6-(C6H6)Ru(pprip)Cl]+ and [η6-(C6H6)Ru(H2iiP)Cl]+ with RNA triplex poly(U)•poly(A)*poly(U). | J Biol Inorg Chem | 2023 | https://conductscience.org/library/papers/37477757 | PubMed |
| 35936428 | Heterodinuclear Ru-Pt Complexes Bridged with 2,3-Bis(pyridyl)pyrazinyl Ligands: Studies on Kinetics, Deoxyribonucleic Acid/Bovine Serum Albumin Binding and Cleavage, In Vitro Cytotoxicity, and In Vivo Toxicity on Zebrafish Embryo Activities. | ACS Omega | 2022 | https://conductscience.org/library/papers/35936428 | PubMed |
| 35744808 | DNA Interaction, DNA Photocleavage, Photocytotoxicity In Vitro, and Molecular Docking of Naphthyl-Appended Ruthenium Complexes. | Molecules | 2022 | https://conductscience.org/library/papers/35744808 | PubMed |
| 35540910 | An investigation on 3-acetyl-7-methoxy-coumarin Schiff bases and their Ru(ii) metallates with potent antiproliferative activity and enhanced LDH and NO release. | RSC Adv | 2018 | https://conductscience.org/library/papers/35540910 | PubMed |
| 35530785 | Seven membered chelate Pt(ii) complexes with 2,3-di(2-pyridyl)quinoxaline ligands: studies of substitution kinetics by sulfur donor nucleophiles, interactions with CT-DNA, BSA and in vitro cytotoxicity activities. | RSC Adv | 2019 | https://conductscience.org/library/papers/35530785 | PubMed |
| 35492083 | Binuclear and tetranuclear Zn(ii) complexes with thiosemicarbazones: synthesis, X-ray crystal structures, ATP-sensing, DNA-binding, phosphatase activity and theoretical calculations. | RSC Adv | 2020 | https://conductscience.org/library/papers/35492083 | PubMed |
| 35353277 | A Biophysical Study of Ru(II) Polypyridyl Complex, Properties and its Interaction with DNA. | J Fluoresc | 2022 | https://conductscience.org/library/papers/35353277 | PubMed |
| 34833864 | Biological Activity of Triazolopyrimidine Copper(II) Complexes Modulated by an Auxiliary N-N-Chelating Heterocycle Ligands. | Molecules | 2021 | https://conductscience.org/library/papers/34833864 | PubMed |
| 34770744 | Antimicrobial and Anticancer Application of Silver(I) Dipeptide Complexes. | Molecules | 2021 | https://conductscience.org/library/papers/34770744 | PubMed |
| 34350537 | Antiproliferative and antibacterial properties of biocompatible copper(II) complexes bearing chelating N,N-heterocycle ligands and potential mechanisms of action. | Biometals | 2021 | https://conductscience.org/library/papers/34350537 | PubMed |
| 34200469 | Photoinduced DNA Cleavage and Photocytotoxic of Phenanthroline-Based Ligand Ruthenium Compounds. | Molecules | 2021 | https://conductscience.org/library/papers/34200469 | PubMed |
| 33468203 | Comprehensive understanding of the effects of metallic cations on enzymatic hydrolysis of humic acid-pretreated waste wheat straw. | Biotechnol Biofuels | 2021 | https://conductscience.org/library/papers/33468203 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8448115
GET https://conductscience.org/api/papers/v1/8448115/cited_by?page=2